PT - JOURNAL ARTICLE AU - Moritz Z. Kayser AU - Christina Valtin AU - Mark Greer AU - Bernd Karow AU - Jan Fuge AU - Jens Gottlieb TI - Video Consultation in Lung Transplant Recipients during the COVID-19 Pandemic AID - 10.1101/2020.05.12.20093799 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.12.20093799 4099 - http://medrxiv.org/content/early/2020/05/18/2020.05.12.20093799.short 4100 - http://medrxiv.org/content/early/2020/05/18/2020.05.12.20093799.full AB - Background The COVID-19 pandemic has disrupted health care systems worldwide. This is due to the demand for medical resources in other areas as well as concern for the risk of nosocomial SARS-CoV-2 exposure. The interruption of routine care is especially problematic for patients with chronic conditions requiring regular follow-up, such as lung transplant recipients. New methods like telemedicine are needed to provide care to these patients.Methods A retrospective analysis of video consultations (VC) in comparison to on-site visits (OSV) was performed during a six-week period in a lung transplant center in Germany. VC included a structured work-up questionnaire and vital sign documentation.Results During the 6-week study period, 75 VC were performed for 53 patients and 75 OSV by 51 patients occurred. By the end of our study period, 77% of physician-patient contacts occurred via VC. Overall, physician-patient consultations were reduced by 47% in comparison to an equivalent time frame in 2019. In 62% of cases, VC resulted in a concrete clinical decision. For two VC patients, the indication for inpatient admission was established during the consultation. One COVID-19 patient in home quarantine was admitted due to respiratory failure detected by VC. Patient satisfaction with VC was high.Conclusions By transitioning to VC, OSV for lung transplant patients during the COVID-19 pandemic was reduced. VC was well received by the majority of patients. This technology can be adopted to provide care for a wide range of chronic illnesses.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe authors received no specific funding for this work.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are no supplementary data sets pertaining to this manuscript online. Our video consultation guide (Supplement 1) and vital parameter log-sheet (Supplement 2) are attached below (German). https://www.mhh.de/fileadmin/mhh/pneumologie/downloads/Videosprechstunde_Anleitung.pdf https://www.mhh.de/fileadmin/mhh/pneumologie/downloads/pdf/mhh_ltx_tagebuch.pdf